Lineage Cell Therapeutics

Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset
Fierce Biotech
Mon, 12/20/21 - 11:32 pm
Roche
Genentech
Lineage Cell Therapeutics
cell therapy
dry age-related macular degeneration